NFKB1 and cholangitis: Levels of Pellino3 protein increased and p65 phosphorylation decreased after hP-MSC treatment, indicating that hP-MSCs improved the cholangitis phenotype via the Pellino3/nuclear factor κB (NF-κB) pathway (Fig. 8B).